This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn.
A sample size of approximately 110 patients was calculated using a power of 80% at the 5% level of detection for a 2.5 to 3 point difference in the Barthel Index (see the "Analysis of Effectiveness" section below) based on a standard deviation (SD) value of 4. 896 patients with stroke were admitted to hospital over 2 years. Of these, 783 (87%) were not randomised, 205 (23%) patients died in hospital, 571 (64%) were discharged home, 110 (12%) were discharged to a nursing/residential home, 5 (0.6%) patients refused to participate, and a further 10 (1%) were not included for other reasons. 113 patients were included in the study. Of these 113 patients, 54 were included in the HBR group and 59 patients in the early discharge and CST group. The median age was 68 years in the CST group and 71 years in the HBR group.
Study design
The study design was a randomised controlled trial. Randomisation was carried out using a list of computer-generated randomly assigned care options prepared by a statistician and administered solely by a named secretary. No research team member or hospital staff member had access to this list. Groups were followed-up for a period of 12 months. At 12 month follow-up 4 patients had died and 4 were lost to follow-up in the HBR group. In the early discharge and CST group 1 patient had died and seven were lost to follow-up. The research nurses were not involved in providing patient care and were blind at baseline to the group to which a patient was assigned.
Analysis of effectiveness
The analysis of the clinical study was based on treatment completers only. The outcomes used in the analysis were the Barthel Index, the Nottingham ADL measure, the Short-Form 36, quality of life, patient and carer satisfaction and the Carer Strain Index. There were no statistically significant differences between the two groups at baseline in terms of sex or age, and they were also comparable in terms of baseline Barthel Index, Nottingham ADL measure, SF-36 scores, quality of life, patient and carer satisfaction and the Carer Strain Index. patient's assignment group. However, the analysis of the clinical study was based on treatment completers only. Despite this limitation, the authors found that those lost to follow-up did not differ significantly from patients who were followed-up successfully at one year.
Validity of estimate of measure of benefit
The authors did not derive a measure of health benefit. The analysis was therefore, in effect, a cost-consequences study (please see commentary above at "Validity of estimate of measure of effectiveness").
Validity of estimate of costs
All categories of cost relevant to the perspective adopted were included in the analysis, and all relevant costs for each category appear to have been included in the analysis. Quantities and costs were not reported separately, which will limit the generalisability of the results. Resource use was derived from a sub-sample of 38 patients in the study. Even though actual resource units were not reported, the authors did provide results of the statistical tests of resource use between the two groups. Unit costs were derived from the authors' settings and from published sources. Appropriate statistical techniques were undertaken to test for statistically significant differences between the two groups. Since all costs were incurred over one year, discounting was unnecessary. The price year was not reported, which will hamper any future inflationary exercises.
Other issues
Despite sparse research regarding the effectiveness of community stroke rehabilitation services, the authors made appropriate comparisons of their findings with those from other studies, which found similar results. The issue of generalisability to other settings was not addressed. The authors do not appear to have presented their results selectively, and their conclusions reflected the scope of the analysis. The authors reported a further limitation to their study, in that the proportion of eligible patients in their study (13%) was very low, and much lower than in other similar studies. The conclusion that CST is more cost-effective than HBR needs to be treated with caution due to the non-significant cost differences found in the study.
